Wednesday, July 8, 2026

biotech · Glioblastoma · Recurrent Brain Metastases · GTBP

GT Biopharma

GT Biopharma trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Brisbane, USA HQ
1973 Founded
8 Employees
Public company Type
GTBP · NYSE Ticker
Company details
Status
Public
HQ
Brisbane, USA
Founded
1973
Employees
8
Programs
8
Drugs
7
Patents
1
Intelligence · Clinical Trials

GT Biopharma clinical trials

Registry index of 8 ClinicalTrials.gov studies linked to GT Biopharma programs — each row shows trial ID, program name, phase, status, and indication.

GT Biopharma trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for GT Biopharma.

  1. GTM-103 — Approved

    Clinical update
  2. Stereotactic Radiation Therapy — Approved

    Clinical update
  3. Stereotactic Radiation Therapy — Phase 3

    Clinical update
  4. Cesium-131 brachytherapy — Phase 2

    Clinical update
  5. Temozolomide — Phase 3

    Clinical update
  6. GTB-3550 TriKE® Phase I — Phase 2

    Clinical update
  7. GTB-5550 — Phase 1

    Clinical update
  8. Semaglutide — Unknown

    Clinical update

Trial registry

8 studies